NCT00297336View on ClinicalTrials.gov

An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

February 28, 2007

Conditions
Migraine Disorders
Interventions
DRUG

Topiramate

80 patients with diagnosed with migraine

All Listed Sponsors
lead

Janssen Cilag Pharmaceutica S.A.C.I., Greece

INDUSTRY

NCT00297336 - An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine | Biotech Hunter | Biotech Hunter